The AP1 pathway, particularly c-Fos/c-Jun-dependent, regulates VEGF-D in lung cancer,213 with IL-7/IL-7R signaling upregulating VEGF-D via AP1 binding, promoting lymphangiogenesis through enhanced c-Fos/c-Jun heterodimers. Here, JUN is linked to lung cancer.